Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization
Aim: Hypersplenism can occur in patients with Wilson's disease (WD). Surgical splenectomy is a conventional treatment for this condition; however, emotional and neurological deterioration may follow splenectomy.
Liang-Yong Li +4 more
doaj +1 more source
Partial Splenic Embolization Using n-Butyl Cyanoacrylate Glue: A Technical Overview
Partial splenic embolization (PSE) is a minimally invasive alternative to splenectomy for conditions such as hypersplenism, portal hypertension, and splenic artery steal syndrome.
Kausthubh Hegde +3 more
doaj +1 more source
Partial splenic embolization as a rescue and emergency treatment for portal hypertension and gastroesophageal variceal hemorrhage. [PDF]
Pavel V +7 more
europepmc +1 more source
Background Gastro-esophageal variceal hemorrhage (GEVH) is one of the major causes of life-threatening gastrointestinal bleeding in children. Medical, endoscopic, angiographic, and surgical interventions can be utilized in treatment. In this case report,
Büşra Tetik Dinçer +4 more
doaj +1 more source
Endoscopic ultrasound-guided super-selective partial splenic embolization: New embolic material and multiple safety precautions. [PDF]
Wu W +6 more
europepmc +1 more source
Case report: A 65-year-old man presented to Medicine ward for bronchial exacerbation and worsening chronic kidney disease. Abdominal ultrasound (US) was performed with random detection of proximal splenic artery aneurysm (diameter 25 mm).
doaj +1 more source
The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension. [PDF]
Saeki M +11 more
europepmc +1 more source
Analysis of predictors after partial splenic embolization for thrombocytopenia with liver cirrhosis. [PDF]
Ishikawa T +8 more
europepmc +1 more source
Correction: Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly. [PDF]
Lu H, Zheng C, Xiong B, Xia X.
europepmc +1 more source

